AllianceBernstein’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

AllianceBernstein’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,002	Closed	-$42K	–	3030
2016 Q1	$42K	Sell	4,002 -760	-16%	-$15.1K	﹤0.01%	2881
2015 Q4	$140K	Hold	4,762	–	–	﹤0.01%	2817
2015 Q3	$150K	Hold	4,762	–	–	﹤0.01%	2830
2015 Q2	$282K	Buy	4,762 +940	+25%	+$66.3K	﹤0.01%	2776
2015 Q1	$409K	Hold	3,822	–	–	﹤0.01%	2565
2014 Q4	$359K	Buy	3,822 +1,235	+48%	+$118K	﹤0.01%	2617
2014 Q3	$199K	Sell	2,587 -1,110	-30%	-$87.4K	﹤0.01%	2776
2014 Q2	$332K	Buy	3,697 +390	+12%	+$23.9K	﹤0.01%	2648
2014 Q1	$177K	Sell	3,307 -870	-21%	-$28.7K	﹤0.01%	2804
2013 Q4	$105K	Sell	4,177 -150	-3%	-$3.57K	﹤0.01%	2924
2013 Q3	$118K	Sell	4,327 -68	-2%	-$2.19K	﹤0.01%	2965
2013 Q2	$159K	Buy	+4,395	New	+$165K	﹤0.01%	2885

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

AllianceBernstein's PTX Position: Q2 2016 in Review

AllianceBernstein sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 4,002 shares — an estimated $42K sold.

AllianceBernstein first reported a position in PTX in Q2 2013 and held it in 12 quarters. The position peaked at $409K in Q1 2015. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

AllianceBernstein reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
AllianceBernstein sold 4,002 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $42K.
AllianceBernstein first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 12 quarters.
AllianceBernstein's Pernix Therapeutics Holdings, Inc. position peaked at $409K in Q1 2015.
56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on AllianceBernstein's 13F filing for Q2 2016, filed 11 Aug 2016.